MMSI Merit Medical Systems Inc.

Merit Medical Launches Smallest and Shortest Configuration of Elation® Pulmonary Balloon Dilator to Help Meet Critical Patient Need

Merit Medical Launches Smallest and Shortest Configuration of Elation® Pulmonary Balloon Dilator to Help Meet Critical Patient Need

Only balloon configuration specifically designed to dilate small airways, providing minimally invasive treatment to patients with lung obstructions

SOUTH JORDAN, Utah, July 20, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the smallest and shortest configuration in its Elation® Pulmonary Balloon Dilator portfolio.

The unique balloon size fills a critical need in the pulmonary care space. Historically, physicians have relied on single-stage, cardiovascular balloons that were often too large and too long for use in smaller airways. The new Elation balloon—part of Merit’s expanded range of multi-stage pulmonary balloon configurations—allows physicians to accurately match balloon diameter and length to specific small airways in the lungs, bringing treatment options to more patients.

Airway obstructions (blockages) can be life-threatening and may occur directly from trauma, malignancy (cancer), and infection. Airway dilation provides a reliable treatment in both malignant and benign (non-cancerous) situations, restoring airway patency and reducing shortness of breath, which allows healing and helps to improve patients’ quality of life.  

“This is the first dilation balloon with a pulmonary indication that has an appropriate size and length for smaller airways,” said Dr. Ali Sadoughi, director of interventional pulmonology and bronchoscopy services at Montefiore Medical Center. “This new configuration helps me safely dilate challenging strictures, including those in short airways at the lobar and segmental levels without fear of over-dilating past the intended site.”

“The new Elation Pulmonary Balloon Dilator is the only one on the market that allows me to safely and accurately balloon dilate small distal airways,” said Dr. Ankit Dhamija, assistant professor of cardiothoracic surgery at Stony Brook Medicine.

The multi-stage balloon configuration measures 4-5-6 mm x 1.5 cm. In addition to its unique sizing, its kink-resistant catheter allows for several insertions and dilations during a single procedure, potentially eliminating the need to use a second balloon.

Learn more about the .

The Elation family of products belongs to a broader portfolio of pulmonary innovations that offers airway stents, guide wires, bronchoscopy kits, balloon dilators, inflation devices, and accessories used to provide interventional and palliative treatment options.

“The new Elation balloon configuration is a significant addition to our Pulmonary portfolio, because it provides a therapeutic option to patients who would otherwise have none,” said Fred P. Lampropoulos, Merit Medical’s Chairman and CEO. “It is a prime example of how our focus is on understanding the needs of physicians and their patients and bringing innovative solutions to market.”

ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 600 individuals. Merit employs approximately 6,500 people worldwide.

TRADEMARKS Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc. and its subsidiaries in the United States and other jurisdictions.

CONTACTS 

PR/Media Inquiries 

Sarah Comstock 

Merit Medical 

|

INVESTOR INQUIRIES 

Mike Piccinino, CFA, IRC 

Westwicke - ICR 

|



EN
20/07/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Merit Medical Systems Inc.

 PRESS RELEASE

Merit Medical Reports Fourth Quarter and Full Year 2025 Results and Is...

Merit Medical Reports Fourth Quarter and Full Year 2025 Results and Issues Fiscal Year 2026 Guidance Fourth Quarter Highlights† Reported revenue of $393.9 million, up 11%Constant currency revenue* and constant currency revenue, organic* up 10% and up 7%, respectivelyGAAP operating margin of 13.8%, compared to 10.3% in prior year periodNon-GAAP operating margin* of 21.0%, compared to 19.6% in prior year periodGAAP EPS $0.63, up 37%Non-GAAP EPS* $1.04, up 12%Free cash flow* generation of $74.0 million, up 13% Fiscal Year 2025 Highlights† Reported revenue of $1.516 billion, up 12%Constant c...

 PRESS RELEASE

Merit Medical Appoints F. Ann Millner as Chair of the Board and Announ...

Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025 SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit’s Lead Independent Director, as Chair of the Board effective January 5, 2026. Dr. Millner has served as a director of Merit since 2015 and as the Lead Independent Director since July 2021. She prev...

 PRESS RELEASE

Merit Medical to Participate at the J.P. Morgan Healthcare Conference

Merit Medical to Participate at the J.P. Morgan Healthcare Conference SOUTH JORDAN, Utah, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management will participate in the 44th Annual J.P. Morgan Healthcare Conference, which is being held at The Westin St. Francis Hotel in San Francisco, California, January 12-15, 2026. To learn more, visit  Martha G. Aronson, President and Chief Executive Officer, and Raul Parra, Chief Financial Officer, will present a company overview and update on Tuesday, Ja...

Merit Medical Systems Inc: 1 director

A director at Merit Medical Systems Inc sold 10,000 shares at 88.038USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

 PRESS RELEASE

Merit Medical Provides Update on U.S. Reimbursement and Commercial Str...

Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis SOUTH JORDAN, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the U.S. Centers for Medicare & Medicaid Services (“CMS”) has notified Merit that its application for Transitional Pass-Through (“TPT”) incremental payment for WRAPSODY® Cell-Impermeable Endoprosthesis (“CIE”) procedures in the outpatient and ambulatory surgery center (“ASC”) settings requires further conside...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch